Morgan Stanley upgrades Reckitt, downgrades Haleon
Morgan Stanley upgraded Reckitt Benckiser and downgraded Haleon on Friday as it took a look at consumer staples stocks.
The bank lifted Reckitt to 'overweight' from 'equalweight' and upped the price target to 5,500p from 4,600p, saying it was its new "top pick" in home and personal care (HPC).
Morgan Stanley said that after several years of earnings volatility, it expects Reckitt to deliver mid single digit percentage like-for-like growth and high single digit earnings per share growth from 2025, supported by the company's ongoing buyback programme, placing it at the top quartile of EU Staples peers.
"Additionally, the potential sale of the company's Essential Home business later in the year could support further re-rating and capital return," it said. "We acknowledge risks around the ongoing litigation, but argue that is priced in at current levels, leaving the risk/reward positively skewed."
The bank downgraded Haleon to 'equalweight' from 'overweight' but lifted the price target to 410p from 400p.
It said it continues to consider Haleon a core long-term holding owing to its well-positioned portfolio in attractive categories.
"However, after a year of significant outperformance, with shares now trading at a 25% premium to EU Staples, we await a better opportunity to add," Morgan Stanley said.
At 0920 GMT, Reckitt shares were up 2.3% at 5,036p, while Haleon was down 1.7% at 376.50p.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.